Evox Therapeutics raised €80M in a Series C round in Feb 2021. The company is based in Oxford, UK. Investors in the round: Redmile Group. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
